PORTAL | Personalized oncology for refractory and relapsed lymphoma using humanized patient derived othotopic xenografts (ImmunePDOX)
01-04-2018
-31-03-2020
Show more information
Organisation
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE